Although Mon et al. showed that IGHG3 expression correlates with non-small cell lung cancer patients who respond to chemotherapy [59] and all three CLR patients tested by SEREX reacted to the IGHG3 gene product, IgG3 protein levels in low passage CRC samples appeared to be very low. The gene discussed is IGHG3; the disease is non-small cell lung carcinoma.